- Medicenna Therapeutics Corp MDNA11 Clinical Update Call TranscriptAug 09, 2023
- Medicenna Therapeutics Corp at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Medicenna Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Medicenna Therapeutics Corp at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 09, 2023
- Q3 2023 Medicenna Therapeutics Corp Earnings Call TranscriptFeb 07, 2023C$1 (-0.99%)Earnings
- Q2 2023 Medicenna Therapeutics Corp Earnings Call TranscriptNov 04, 2022C$0.88 (-4.35%)Earnings
- Medicenna Therapeutics Corp Annual Shareholders Meeting TranscriptSep 21, 2022
- Q1 2023 Medicenna Therapeutics Corp Earnings Call TranscriptAug 15, 2022C$1.27 (-6.62%)Earnings
- Q4 2022 Medicenna Therapeutics Corp Earnings Call TranscriptJun 22, 2022C$1.27 (+14.41%)Earnings
- Medicenna Therapeutics Corp at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 02, 2022
- Q3 2022 Medicenna Therapeutics Corp Earnings Call TranscriptFeb 09, 2022C$2.31 (-2.53%)Earnings
- Q2 2022 Medicenna Therapeutics Corp Earnings Call TranscriptNov 12, 2021C$2.56Earnings
- Medicenna Therapeutics Corp Annual Shareholders Meeting TranscriptSep 23, 2021
- Medicenna Therapeutics Corp at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Q1 2022 Medicenna Therapeutics Corp Earnings Call TranscriptAug 13, 2021C$2.61 (-4.74%)Earnings
- Medicenna Therapeutics Corp MDNA11 Program Update Call TranscriptJul 27, 2021
- Q4 2021 Medicenna Therapeutics Corp Earnings Call TranscriptMay 28, 2021C$4.7 (-0.42%)Earnings
- Medicenna Therapeutics Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Medicenna Therapeutics Corp. - Special Call TranscriptDec 11, 2020
- Medicenna Therapeutics Corp. - Special Call TranscriptMar 25, 2020
- Medicenna Therapeutics Corp to Host Key Opinion Leader Call Focused on Latest MDNA55 Recurrent Glioblastoma Phase 2b Clinical Study Results TranscriptNov 25, 2019
Medicenna Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Hey, good afternoon, everyone. Thanks for joining the Annual Healthcare Conference. My name is Matt Biegler. I'm a covering analyst here. Pleased to be joined by one of my covered companies, which is Medicenna. We're with CEO, Fahar Merchant. Fahar, welcome.
Thank you, and thank you, Matt, for inviting us to participate in your conference today.
Questions & Answers
We are going to be doing a fireside chat for those interested. So maybe I'll just start with the high level question. I think a lot of people think of medicine as kind of a one trick pony in the IL-2 space, with a modified IL-2 agonist, which is MDNA11. We'll obviously talk a lot about -- a lot of it I've heard about that today. But there's much more to Medicenna, I guess, that you guys have under the hood. So maybe if you can just walk us through the story and what you guys are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)